Pharma & Biopharma

Discussing the multidisciplinary engineering challenge that is developing increasingly small mass spectrometry instruments with Kevin J. Knopp

Three experts from Agilent Technologies discuss the role of new analytical advances in the march towards continuous bioprocessing

The Intabio ZT system couples imaged capillary isoelectric focusing (icIEF) to mass spectrometry

How THz-TDS paired with neural network can assess burn severity with 93 percent accuracy

The steps we can take to reduce liquid chromatography’s impact on the environment

With new vaccines come new challenges – and the need for new tools. Can mass spectrometry solve the problem of impurities?

We spoke with the minds behind this year’s scientific program – Michael Laemmerhofer and Oliver J. Schmitz – to find out how HPLC is shaping up

With many biologics patents soon to expire, can multimodal chromatography meet the growing demand for efficient downstream biosimilar production?

A single VUV system could replace a number of separate analytical techniques employed during API design and pharma manufacturing

How advances in next-generation sequencing are expanding the horizons of pharmacogenomic testing